KSE - Delayed Quote KRW

SAMSUNG PHARM. Co., LTD. (001360.KS)

1,614.00
-3.00
(-0.19%)
At close: 3:30:25 PM GMT+9

Key Executives

SAMSUNG PHARM. Co., LTD.

10, Yakgongdan 4-gil
Hyangnam-eup
Hwaseong-si, 445-746
South Korea
82 3 1353 6681 https://www.sspharm.co.kr
Sector: 
Healthcare

Description

SAMSUNG PHARM. Co., LTD. manufactures and sells pharmaceutical products in South Korea. It offers prescription medicines, such as anticancer immunotherapy, antipyretic analgestic and antiinflammatory, antiobesity, hypotensive, antiarteriosclerotic, digestive organs, antophlegms, enzymes, ostepoposis, and transfusion agents, as well as skeletal muscle relaxants, anti-spastic, mixed vitamins, antibiotics, and others. The company also provides medicines for digestive system, medicines for liver disorder, medicines for circulation system, cold medicines, nutritional supplements, health tonics, antophlegm agents, and others, as well as quasi-medicines, vitamins and energy drinks, and functional foods. The company was founded in 1929 and is headquartered in Hwaseong-si, South Korea.

Corporate Governance

SAMSUNG PHARM. Co., LTD.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

August 12, 2025 at 10:59 AM UTC - August 18, 2025 at 12:00 PM UTC

SAMSUNG PHARM. Co., LTD. Earnings Date

Recent Events